Keeps offers FDA-approved hair loss medications delivered to customers' doors. Its Care Team helps customers find a hair treatment plan based on their answers to a few questions.
Remedy Meds has entered into a definitive agreement to acquire Thirty Madison for just over $500 million in an all-stock transaction. The deal combines telehealth brands serving women’s health, men’s health, and metabolic conditions under one platform. It brings Remedy Meds’ weight loss platform together with Thirty Madison’s portfolio, including Nurx for women’s health.
Remedy Meds, a consumer virtual-care and pharmacy platform, announces a definitive agreement to acquire Thirty Madison. The planned acquisition is described as expanding its telehealth capabilities across men's, women's, and metabolic health.
Hims, Keeps, Roman, and other providers offer hair-loss treatments delivered directly to customers’ homes, without requiring a pharmacy trip. The nine options are presented as proactive ways to address hair loss from home, without a doctor’s office visit.
Keeps, a men's hair loss brand, has raised $15 million in a funding round co-led by Maveron and Northzone. Its parent company, Thirty Madison, raised the money to fight male pattern baldness.